Finance

Lists
603983:SHA
Guangdong Marubi Biotechnology Co Ltd
CNÂ¥34.30
+0.62%
(+0.21) 1D
Sep 8, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603983...
Open
CNÂ¥33.84
High
CNÂ¥34.57
Low
CNÂ¥33.20
Mkt. cap
13.67B
Avg. vol.
5.37M
Volume
7.28M
Dividend
1.46%
Quarterly dividend
CNÂ¥0.13
Ex-dividend date
Jul 16, 2026
P/E ratio
63.37
52-wk high
CNÂ¥41.77
52-wk low
CNÂ¥21.20
EPS
CNÂ¥0.54
No. of employees
1K
Open
CNÂ¥33.84
High
CNÂ¥34.57
Low
CNÂ¥33.20
Mkt. cap
13.67B
Avg. vol.
5.37M
Volume
7.28M
Dividend
1.46%
Quarterly dividend
CNÂ¥0.13
Ex-dividend date
Jul 16, 2026
P/E ratio
63.37
52-wk high
CNÂ¥41.77
52-wk low
CNÂ¥21.20
EPS
CNÂ¥0.54
No. of employees
1K
About Guangdong Marubi Biotechnology Co Ltd
CEO-
Employees1.38K
FoundedApr 2, 2002
Headquarters-
SectorPersonal care products
Websitemarubi.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
681.19M
1.01B
881.29M
781.79M
Cost of goods sold
164.07M
278.10M
230.72M
207.55M
Cost of revenue
164.07M
278.10M
230.72M
207.55M
Research and development expenses
22.09M
22.58M
20.55M
24.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
465.72M
701.76M
505.93M
542.40M
Operating expense
489.86M
744.45M
531.68M
571.97M
Total operating expenses
653.93M
1.02B
762.40M
779.52M
Operating income
27.26M
-13.61M
118.89M
2.27M
Other non operating income
-812.89K
-619.64K
-182.86K
4.51M
EBT including unusual items
57.75M
-2.79M
123.23M
59.61M
EBT excluding unusual items
45.95M
-1.29M
123.81M
65.64M
Income tax expense
-2.86M
-2.88M
22.23M
3.65M
Effective tax rate
-4.96%
103.35%
18.04%
6.13%
Other operating expenses
2.86M
20.49M
5.81M
4.93M
Net income
58.15M
3.35M
101.02M
54.45M
Net profit margin
8.54%
0.33%
11.46%
6.96%
Earnings per share
-
-
-
-
Interest and investment income
19.60M
13.50M
7.79M
58.86M
Interest expense
-33.31K
-592.98K
-2.68M
-
Net interest expenses
19.57M
12.90M
5.10M
58.86M
Depreciation and amortization charges
-
-
-
-
EBITDA
32.64M
1.09M
133.59M
18.65M
Gain or loss from assets sale
377.40K
-377.40K
-
-
AI content may include mistakes. Learn more
Google apps